NMN Sublingual Tablets

Name: Renue By Science NMN Sublingual Tablets
Brand: Renue By Science
Price: 50.00 USD
Availability: InStock

Solid ChoiceLongevity & Anti-Aging

A sublingual NMN tablet designed to bypass first-pass liver metabolism for potentially better bioavailability. Renue By Science (formerly Alive By Science) is a longevity-focused brand that has invested in liposomal and sublingual delivery systems. The sublingual approach is scientifically reasonable but unproven to be superior in human trials.

70/ 100

Biorank Score

Independently ranked

70/ 100

Biorank Score

Independently ranked by Biorank Laboratories

Our Verdict

Solid Choice

Renue By Science scores 70 for offering an innovative delivery mechanism (sublingual) that has a solid pharmacokinetic rationale even though it lacks published comparative human data. The formulation score (78) is the highest sub-score because the sublingual approach is scientifically reasonable. The evidence score (64) is lower because the delivery advantage is theoretical, not proven. No hype penalty because the brand does not make outrageous claims about the sublingual format.

Key Findings

Sublingual delivery bypasses first-pass liver metabolism — pharmacokinetically reasonable approach
No published human trial comparing sublingual vs oral NMN — advantage is theoretical
Renue By Science (formerly Alive By Science) specializes in advanced delivery formats
Formulation innovation is the product's strongest feature, but empirical validation is lacking
Same NMN molecule and evidence base as all other NMN products

Evidence Analysis

The rationale for sublingual NMN delivery is pharmacokinetic: sublingual absorption bypasses first-pass hepatic metabolism, potentially delivering more intact NMN to systemic circulation. This is a well-established principle in pharmacology (nitroglycerin, some hormones). However, no published human trial has compared sublingual vs oral NMN bioavailability. The NMN evidence base remains the same as other NMN products: Yoshino et al. (2021), Igarashi et al. (2022). Renue By Science has conducted internal testing suggesting higher blood NAD+ levels with sublingual delivery, but this has not been published in a peer-reviewed journal. The delivery innovation is theoretically sound but empirically unvalidated.

Ingredient Breakdown

Ingredient	Dose	Effective Dose	Adequacy	Verdict
Nicotinamide Mononucleotide (NMN) — sublingual	500mg	250-500mg (based on early trials)		Optimal

True Cost Analysis

Properly Dosed -- What You Pay Is What You Get

Listed Price

$1.67/serving

$50.10/month at 1 serving/day

True Cost Per Effective Dose

$1.67/effective dose

$50.10/month for effective dosing

Value Score

Decent value

Save $45.60/month (91%)

by switching to NOW Foods Quercetin 500mg

Where It Falls Short

No published human trial comparing sublingual vs oral NMN bioavailability — the delivery advantage is theoretical. The sublingual format requires holding the tablet under the tongue for 2-3 minutes, which some users find inconvenient. At $1.67/serving, it is mid-range for NMN but expensive for an unproven delivery mechanism. Renue By Science rebranded from Alive By Science, which may cause confusion. The same NMN evidence limitations apply across all brands.

Best For

Longevity enthusiasts who understand sublingual pharmacokinetics and want to optimize absorption
Those who have tried oral NMN and want to experiment with a different delivery format
Biohackers who track NAD+ levels and can personally test whether sublingual delivery makes a difference
People who prefer not to swallow capsules

Not Ideal For

Anyone expecting proven bioavailability advantages (no published comparative data exists)
People who find sublingual administration inconvenient
Budget-conscious consumers (the delivery premium is not evidence-justified)
Those who prefer the simplicity of a standard capsule format